Jason Hope´s Thoughts on the New Longevity Research

Over the years, various topics related to the use of stem cells have been discussed on various media platforms. From being hailed as an innovative method for treating diseases to being protested, the use of stem cells gained widespread attention. According to Jason Hope, in 1992, scientists were able to successfully grow human embryonic stem cells in a lab. 


Jason Hope explains that this procedure allowed them to create batches of cells that can be used to develop treatments for various conditions such as stroke and Alzheimer’s disease. Entrepreneur and activist investor, who is also an expert in the field of anti-aging, commended the initial success of the laboratory process. However, he noted that more research is needed before stem cells can truly be utilized in medicine. He also noted that the general public tends to distrust companies that make outlandish claims about their products. 


Forbes Magazine on Jason Hope


This is because they are not yet able to prove their claims to the medical community. Aside from the studies being conducted by the SENS, other studies are also being conducted on the use of stem cells in various medical conditions. One of these studies involved transplanting retinal cells into patients with age-related macular degeneration. As an entrepreneur, Jason Hope understands the challenges that stem cell researchers and companies are going through to successfully integrate technology into medicine. 

Aside from the supply chain issues that stem cell companies are likely to encounter, he also noted that the hype surrounding the field could also cause long-term side effects. Aside from being an entrepreneur, he is an avid philanthropist and a passionate advocate for technological advancements. Jason Hope is heavily involved in the scientific community. He is passionate about the field of biomedicine and its potential to improve the human lifespan. After graduating from the W.P. Carey School of Business, Hope founded a mobile communications company.